The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.
PLoS ONE. 2010; 5(8):e12250
Cassian Sitaru and Florina Florea
29 Sep 2010
|
New Finding
In the present study, Schepens et al. identify the p170 antigen targeted by paraneoplastic pemphigus (PNP) antibodies as the protease inhibitor alpha-2-macroglobulin-like-1 (A2ML1). This study gives us new insight into the pathogenesis of PNP.
PNP is a severe and often fatal autoimmune mucocutaneous blistering disease, with gastrointestinal...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.